UNSPSC 51102848: Fluorometholone/sulfacetamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102848 Fluorometholone/sulfacetamide is a Commodity code for ophthalmic and systemic pharmaceutical products. State and local procurement activity under this code does not align clearly with the code's nominal scope — the recent opportunities posted against it center on antibiotic tablets, naloxone, and drug deactivation systems rather than fluorometholone or sulfacetamide formulations. Illinois Department of Public Health and Seminole County, Florida have posted pharmaceutical procurement notices under related codes in the past six months, but neither directly solicits the fluorometholone or sulfacetamide products the code nominally describes. The issuing bodies active in this pharmaceutical space include state health departments and county health authorities procuring bulk pharmaceutical supplies through cooperative purchasing vehicles (MMCAP Infuse) and competitive sealed bidding.

Geographic activity concentrates in Florida and Illinois based on recent postings. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for antibiotic tablets (Doxycycline and Ciprofloxacin), with a 12-month initial term and renewal options totaling $2,999,999.11 over the life of the contract. Seminole County, Florida posted an IFB in June 2026 for 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding, with quarterly deliveries and a two-year initial term plus one-year renewal option. The mismatch between the code's nominal scope and the products actually solicited suggests this code may be tagged inconsistently in state and local systems, or that fluorometholone and sulfacetamide procurement under this specific code shows minimal recent activity in the sourced records.